Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Shiyitang Pharmaceutical is a prominent Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM) and modern pharmaceutical preparations. As a core subsidiary of the Harbin Pharmaceutical Group (Hayao), Shiyitang operates as a 'China Time-honored Brand' with a history dating back to 1903. The company’s extensive product portfolio includes over 100 varieties of TCM formulations such as pills, powders, oral liquids, and injections, covering therapeutic areas like respiratory health, cardiovascular disease, and orthopedics. Shiyitang is recognized for integrating centuries-old traditional recipes with modern manufacturing standards and rigorous quality control to serve the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shiyitang.